Amgen settlement to provide West Virginia more than $845,000
A multistate settlement with Amgen Inc. will provide West Virginia more than $845,000, says Attorney General Patrick Morrisey. A $71 million settlement with drug maker Amgen was over accusations of deceptive drug marketing practices.
Attorneys general from 48 states and the District of Columbia had unanimously said that Amgen illegally promoted the drugs Aranesp and Enbrel, which put many consumers at serious health risk. Besides, consumers were exposed to high costs of the drugs.
Aranesp targets anemia, whereas Enbrel is meant for treating moderate to severe plague psoriasis and other conditions. Amgen faced accusations of deliberately exaggerating effectiveness of the drugs to consumers.
“Deceptive marketing practices will not be tolerated. This settlement protects Arizona consumers and will help ensure that deceptive advertising plays no part in future consumer prescription drug choices”, Arizona Attorney General Mark Brnovich said in a statement.
The settlement involves dosing schedule of Aranesp, marketing of the drug as a treatment for anemia caused by cancer and promotion of Enbrel as a treatment for mild plaque psoriasis. Approval of Enbrel is only allowed for chronic moderate to severe plaque psoriasis.
The net profit margin of the firm was a positive 28%, whereas its operating margin was 36.80%.
The overall ‘asthma epidemic’ among children has...Read More
People in huge numbers gathered in the Mount Lofty...Read More
As New Year is approaching, people have already...Read More
Alzheimer’s disease, the commonest cause of...Read More
Cases of opioid abuse have been increasing and...Read More
In an announcement made on December 22, cable giant...Read More